PRINT SCHEDULE
SPEAKERS
SUNDAY MONDAY TUESDAY WEDNESDAY
 
 SUNDAY

TOPICAL REVIEWS:

   

Mark Hill, PhD, MS
University of Oxford

Dorthe Schaue, PhD
David Geffen School of Medicine- UCLA
Olga Martin, PhD
Peter MacCallum Cancer Centre
 Karl Butterworth, PhD 
Queen's Belfast University
PLENARY LECTURE: Visualising the Future - Imaging for Translational Radiation Research

Dr. David Jaffray, PhD, AMBP
Dr. David Jaffray graduated from the University of Alberta with a B.Sc. in Physics (Hons.) in 1988 and completed his Ph.D. in the Department of Medical Biophysics at the University of Western Ontario in 1994.  Following graduation, he took a position as Staff Physicist in the Department of Radiation Oncology at William Beaumont Hospital in Michigan where he instigated a direction of research that garnered funding from the NIH and from congressionally-directed funding programs.  Dr. Jaffray became a Board Certified Medical Physicist (ABMP – Radiation Oncology) in 1999.  In 2002, Dr. Jaffray joined the Princess Margaret Hospital in Toronto as Head of Radiation Physics and a Senior Scientist within the Ontario Cancer Institute.

David holds the Fidani Chair in Radiation Physics, is the Director of the TECHNA Institute for Health Technology Development at the University Health Network and recently became the Executive Vice President of Technology and Innovation at the University Health Network. He is a Professor in the Departments of Radiation Oncology, Medical Biophysics, and Institute for Biomaterials and Biomedical Engineering at the University of Toronto.  His primary area of research has been in the development and application of image-guided therapy.  He has over 5 patents issued and several licensed, including, kilovoltage cone-beam computed tomography for image-guided radiation therapy.

Dr. Jaffray has >200 peer-reviewed publications in the field, >100 invited lectures, and holds numerous peer-review and industry sponsored research grants.  He sits on numerous scientific and research boards and has contributed to the NIH and CIHR grant review process for several years.  He is an active member of the AAPM and teaching role in workshops and annual meeting of the American Society of Therapeutic Radiation Oncology (ASTRO).   He has an active interest in commercialization and led the development of a variety of commercial products including software and hardware for QA and the development of small animal irradiator systems for basic research.  He has successfully supervised over 20 graduate students and fellows.

Dr. Jaffray has won each of the major prizes in the field of the medical physics, including, the Sylvia Sorkin-Greenfield Award, The Farrington Daniels Award, and the Sylvia Fedoruk Award.  In 2004, Dr. Jaffray was identified as one of Canada’s Top 40 Under 40 and was recognized by The University of Western Ontario with their Young Alumni Award in 2004. His current research interests focus on the development of imaging technologies and methods with a focus on image-guided interventions, including radiation therapy, drug delivery, and surgery.
 
SYMPOSIUM 1: Cancer Therapies and CTC's
 
Michael McManus, MB Bch BAO, MD, MRCP, FRANZCR
Peter MacCallum Cancer Centre
Urbain Weyemi, PhD
Johns Hopkins University
Maria Alieva, PhD
Hubrecht Institute
Edward Graves, PhD
University of Stanford
 
SYMPOSIUM 2: The RBE of Proton Beam Therapy and its Clinical Significance
   
Henning Willers, MD
Massachusetts General Hospital
 Claudia Wiese, PhD, MS, BS
Colorado State University
Stephan McMahon, PhD
Queen's University Belfast
Claere Von Neubeck, PhD
National Center for Radiation Research Oncology
David Grosshans, MD, PhD
University of Texas MD Anderson Cancer Center
SYMPOSIUM 3: The Chemistry of DNA Damage, Repair and Molecular Radiotherapy
   
Mike Sevilla, PhD
Oakland University
Marc Greenberg, PhD
Johns Hopkins University
 Amitava Adhikary
Oakland University
Rebecca Abergel, PhD
Lawrence Berkeley National
Laboratory
SYMPOSIUM 4: Synthetic Lethality Revisited: Tumor-Selective Use of PARP Inhibitors for Anti-Cancer Therapy
         
Zihua Gong, MD, PhD
Cleveland Clinic Lerner College of Medicine 

Xiumei Huang, PhD
Simmons Comprehensive Cancer Center, UT
Southwestern Medical Center

Edward Motea, PhD
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
Ashley Schlafstein
Augusta University
David Boothman, PhD
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center
SYMPOSIUM 5: Therapeutic Radiation Induced Delayed Vascular Damage
         
Adriana Haimovitz-Friedman, PhD
Memorial Sloan Kettering Cancer Center
Martin Hauer-Jensen, MD, PhD, FACS
University of Arkansas for Medical Sciences
Natarajan Aravindan, PhD
University of Oklahoma Health Science Center

 Merriline Satyamitra, MS, PhD
NIAID of the National Institute of Health
Meenakshi Upreti,PhD
College of Pharmacy, University of Kentucky
 
SYMPOSIUM 6: Harnessing the Power of Metabolism to Improve Radiation Therapy
     

Nicolaas E Deutz, MD, PhD
Department of Health & Kinesiology,
Texax A & M University

Amrita Cheema, PhD, MS
Georgetown Lombardi
Comprehensive Cancer Center
Igor Koturbash, MD, PhD
University of Arkansas for Medical
Sciences
Melissa Fath, PhD
University of Iowa
Gunnar Boysen, PhD
University of Arkansas for Medical Sciences
 
SYMPOSIUM 7: Space Radiation and Normal Tissue Injury
          
Marta Rovituso, PhD
Trento Institute for Fundamental Physics and Applications 
Thomas Berger, PhD
German Aerospace Center- Institute of Aerospace Medicine
Amelia Eisch, PhD
UT Southwestern Medical Center, Children's Hospital of Philadelphia
Scott Welford, PhD
Case Western Reserve University
 Cynthia Lemere, PhD
Brigham & Women's Hospital, Harvard Medical School
 
SYMPOSIUM 8: Low Dose Radiation Responses and Implications For Risk
   
Edouard Azzam, PhD, MS
Rutgers NJ Medical School
Carmel Mothersill, PhD
McMaster University
Munira Kadhim, PhD
Oxford Brookes University
David Pawel, PhD
EPA Office of air and Radiation
 
SYMPOSIUM 9: Pioneering Radiobiology - Then and Now - A History Symposium to Honor Jack Fowler and Sir Oliver Scott
     
Colin Seymour, PhD
McMaster University

Elizabeth Travis, PhD, FASTRO
University of Texas MD Anderson
Cancer Center

Mary-Keara Boss, DVM, PhD
Colorado State University
Soren Bentzen, PhD, DMSc
University of Maryland
School of Medicine
 
SYMPOSIUM 10: STEM CELL BIOLOGY AND RADIOTHERAPY
 
       
 Tej Pandita, PhD
Houston Methodist
Research Institute
 Robert P. Coppes, PhD
University of Groningen
 John P. Cooke, MD, PhD
Houston Methodist
 Kalpana Mujoo, PhD
Houston Methodist

 
FAILLA LECTURE
  Dale L. Preston, PhD
Dale Preston has a B.S in mathematics from Humboldt State University, Arcata, CA and an M.S. and a Ph.D in Biostatistics from UCLA. In 1981, after athree years at Bell Labs, he began working on atomic bomb survivor studies at the Radiation Effects Research Foundation in Hiroshima, where he worked for the next 23 years, While at RERF he developed a class of risk regression models and modelling software that are widely used for dose-response modelling in radiation epidemiology and other areas, took a lead role in the preparation of major reports on radiation effects on cancer and non-cancer mortality and incidence rates in the survivor cohorts, and oversaw the implementation of two new dosimetry systems. He has had a 30-year association with the Radiation Epidemiology Branch of the US National Cancer Institute and has worked on studies of the Russian Mayak Worker and Techa River cohorts for more than 25 years. Since returning to the US in 2004, Dr Preston has continued to work on the analyses of cancer risks in the atomic bomb survivors, Mayak Workers, Techa River residents, US radiologic technologists, and other exposed populations. Other professional activities include service as a consultant to UNSCEAR and various BEIR committees, as a member of ICRP Committee 1, and as an associate editor of Radiation Research. He is a fellow of the American Association for the Advancement of Science and the American Statistical Association and an author of almost 200 peer-reviewed articles.
 
 MONDAY
TOPICAL REVIEWS
     
Douglas Spitz, PhD
University of Iowa
Harald Paganetti, PhD
Massachusetts General Hospital-
Radiation Oncology,
Harvard Medical School
Lorenzo Galluzzi, PhD
Weill Cornell Medical College, NYC-
Division of Radiation Oncology
Gayle Woloschak, PhD
Northwestern University
 
PLENARY LECTURE: Genomics in the Era of Advanced Radiotherapy

Professor Catharine West, PhD
Catharine West obtained a PhD in radiobiology in 1983 at the Institute of Cancer Research in Sutton. During this time she developed an interest in measuring radiosensitivity and hypoxia. Following postdoctoral work at the University of Rochester Cancer Center in upstate New York, she moved to the Paterson Institute/Christie Hospital in 1986. In 2002, she moved to the University of Manchester where she became Professor of Radiation Biology in 2007.

She has been a member/officer of a number of UK Radiation Biology committees and UK Clinical Study Groups. She is currently an associate editor for Radiation Research, on the editorial board for Clinical Oncology, on the Prostate Cancer UK Research Advisory Committee, an honorary member of the Royal College of Radiologists and honorary fellow of the British Institute of Radiology. She is a past member on the UK Committee on Medical Aspects of Radiation in the Environment and past Chair of the LH Gray Memorial Trust. In 2016 the UK Association for Radiation Research awarded her the Weiss medal.

Her work focuses on measuring radiobiologically relevant phenotypes in cancer patients with a particular interest in translational research linked to trials involving radiotherapy. She was instrumental in setting up the international Radiogenomics Consortium. Catharine has three children, worked part-time for a number of years, has published over 250 papers and has an h-index of 55. She has been a member of RRS since 1986.

 
SYMPOSIUM 11: RRS/COSPAR Joint Symposium: The Future of Space Missions
       
John Norbury, PhD
NASA Langley Space Radiation Lab
Guangming Zhou, PhD
School of Radiation Medicine and
Protection, Soochow University
Captain Christopher Cassidy, PhD, MS
NASA- Extravehicular Activity

Santosh Kumar, PhD
Georgetown University, 
Washington DC

Katherine Castle, PhD
Duke University
 
SYMPOSIUM 12: Role of Innate Immune Cells in the Response to Radiation
     
Sandra Demaria, MD, PhD
Weill Cornell Medicine
Karsten Pilones, MD, PhD
Weill Cornell Medical College
Marka Crittenden, PhD, MD
The Oregon Clinic- Radiation Oncology
Arta Monir Monjazeb, MD, PhD
UC Davis
 
SYMPOSIUM 13: Chromatin Remodeling
     
Amy Strom
Lawrence Berkeley National Lab
UC Berkeley
Samuel Bakhoum, MD, PhD
Memorial Sloan Kettering
Mitchell Turker, PhD, JD
Oregon Institute of Occupational
Health Sciences
Michael Hendzel, PhD
University of Alberta 
 
SYMPOSIUM 14: The Potential of Nanoparticles: How Sophisticated Can We Get and What is the Potential for Clinical Translation
     
James W. Tunnell, PhD
University of Texas Austin
 Maureen Aliru, BS
University of Texas,
MD Anderson Cancer Center
Sunil Krishnan, MD, FACP
University of Texas,
MD Anderson Cancer Center
Jan Schuemann, PhD
Massachusetts General
Hospital
 
SYMPOSIUM 15: Prostate Cancer Genomics and Targeting to Improve Radiotherapy
 
Peter Nelson, MD
University of Washington Medicine
Felix Feng, MD
University of California
Rob Bristow, PhD, FRCPC
Ontario Cancer Institute,
University of Toronto
Laure Marignol, PhD
Trinity College Dublin
 
SYMPOSIUM 16: Radiation and Circulatory Disease
 
 Mark Little, PhD
National Institute of Health-
Radiation Epidemiology
 Meetha Medhora, PhD
Medical College of Wisconsin
 Daniel A. Mulrooney, MD, MS
St. Jude- Oncology & Epidemiology/
Cancer Control Departments
Weng-Lang Yang, PhD
Feinstein Institute for Medical Research 
 
SYMPOSIUM 17: Radiation-Drug Combinations to Improve Clinical Outcome and Reduce Normal Tissue Toxicity
       
Richard Amos, MSc
University College London
Yaacov Lawrence, MD
Sheba-Tel HaShomer Hospital,
Thomas Jefferson University
Kelly Falls, PhD
University of Iowa 
 Sunil Advani, MD
Moores Cancer Center, UC San Diego

 
SYMPOSIUM 18: Signaling and Therapy for Combined Radiation Injury
       
Juliann Kiang, PhD
Uniformed Services University of the Health Sciences, Armed Forces Radiobiology Research Institute
Jackie Williams, PhD
University of Rochester Medical Center
R. Joel Lowy, PhD
Uniformed Services University of the Health Sciences
John Moulder, PhD
Emeritus- Medical College of Wisconsin
 
MICHAEL FRY AWARD LECTURE
  Igor Koturbash, MD, PhD
Dr. Igor Koturbash is an Assistant Professor at the Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR. He received his MD (with honors) from the State Medical University in Ivano-Frankivsk, Ukraine, and his PhD in Molecular Biology from the University of Lethbridge, Canada. The main focus of Igor’s research is devoted to modulation of the normal and tumorous tissue response to ionizing radiation by targeting the epigenetic and metabolic pathways. Dr. Koturbash is author/co-author of over 70 peer-reviewed articles and book chapters. His research is funded by NIH, NSBRI, NIOSH and DOJ. Igor is a recipient of numerous prestigious awards, including Alberta Cancer Board/Cyril M. Kay Graduate Studentship Award and the Faculty Award for Excellence in Research from UAMS. He has been a member of the Radiation Research Society since 2005 and currently serves as a Vice-President for the South-Central Chapter of the Society of Toxicology.
 
MARIE CURIE AWARD LECTURE
 

Nils-Petter Rudqvist, MD, PhD
Nils-Petter Rudqvist received his M.Sc. in Physics in 2009, and Ph.D. in Medical Science in 2015 from the University of Gothenburg, Sweden. Determined to pursue an academic career, he joined the lab of Dr. Amundson at Columbia University in New York City for one year of postdoctoral training. Intrigued by the emerging role of radiation in cancer immunotherapy Nils-Petter decided to join the lab of Dr. Demaria at Weill Cornell Medicine (New York, NY) where he is currently a postdoctoral associate in radiation oncology. His research project is focused on investigating the mechanisms whereby radiation therapy can convert a tumor into an in situ individualized vaccine. In particular, Nils-Petter is leveraging his multidisciplinary background to determine to which extent radiation effectively exposes the tumor neoantigen reservoir to the immune system. His project encompasses both mouse tumor models as well as patients-derived samples. He has published 16 articles in peer-reviewed scientific journals and 60+ scientific conference abstracts. Nils-Petter’s long-term career goal is to become an independent investigator within the field of radiation and immunotherapy.

 
 TUESDAY
TOPICAL REVIEWS
        
Marie-Catherine Vozenin, PhD, HDR
Centre Hospitalier Universitaire
Vaudois
Harry Cullings, PhD, MS
Radiation Effects Research
Foundation
Marianne Koritzinsky, PhD
University of Toronto
Olga Kovalchuk, PhD, MS, BMed
University of Lethbridge
 
PLENARY LECTURE: Immune Modulation of Radiation Response: Chasing the Drivers!

Professor Mary Helen Barcellos-Hoff, PhD
Dr. Barcellos-Hoff received an undergraduate degree from the University of Chicago and earned a doctoral degree in experimental pathology from the University of California, San Francisco. She conducted postdoctoral research on extracellular matrix mediated functional differentiation at the Lawrence Berkeley National Laboratory (LBNL), which she joined as a staff scientist and rose to Senior Scientist and Associate Director of the Life Sciences Division before joining the Department of Radiation Oncology of New York University School of Medicine in 2008.

In 2015, she joined UCSF as Professor and Vice Chair of Research in the Department of Radiation Oncology. The Barcellos-Hoff laboratory studies breast cancer, mammary biology radiation carcinogenesis, and mechanisms to biologically augment radiotherapy and is also interested in application of systems biology approaches to problems in radiation research.

 
SYMPOSIUM 19: Precision Medicine in Radiation Oncology
         
Gillies McKenna, MD
University of Oxford
Eileen Connolly, MD, PhD
New York Presbyterian/Columbia University Medical Center
Simon Powell, MD, PhD
Memorial Sloan Kettering Cancer Center
Jennifer Yu, MD, PhD
Lerner Research Institute of Cleveland Clinic

John Ng, MD
New York Presbyterian,
Weill Cornell University
 

 
SYMPOSIUM 20: ISRN/RRS Joint Symposium: Raidation Neurobiology - From Basic Science to the Clinic
        
Noriko Koganezawa, PhD
Gunma University Graduate
School of Medicine
 Roman Vlkolinsky, PhD
School of Medicine at
Loma Linda University
Aimee McNamara, PhD
Massachusetts General Hospital
Takako Yasuda, PhD
University of Tokyo 
 
SYMPOSIUM 21: Recent Advances in Radiobiophotonics, Nanomedicine and Imaging
           
Lei Xing, PhD
Standford Medicine  
Jan Grimm, MD, PhD
Jan Grimm Lab- Memorial Sloan
Kettering Cancer Center
 
Premkumar Saganti, PhD
Prairie View
A & M University
 
Nalinikanth Kotagiri, PhD
University of Cinncinati 
Gabriel Sawakuchi, PhD
MD Anderson Cancer Center 

SYMPOSIUM 22: Advances in Radionuclide Therapies
        
James Gulley, PhD
National Cancer Institute Center for Cancer Research
Roger Howell, PhD
Rutgers NJ Medical School
Roger Martin, PhD
Peter MacCallum Cancer Centre
Robert Hobbs, PhD
Johns Hopkins Medicine
 
 
WEDNESDAY
TOPICAL REVIEWS
        
David Yu, MD, PhD
Emory University School of
Medicine, Grady Memorial Hospital
David Brenner, MD, PhD
Center for Radiological
Research-Columbia
Chuan-Yuan Li, DSc
Duke University School of Medicine
Erina Vlashi, PhD
UCLA- Radiation Oncology
 
PLENARY LECTURE: The Choreography of DNA Repair: A Structural Perspective
 

John Tainer, PhD
John Tainer has studied biologically-interrelated stress responses for reactive oxygen, immune activation, pathogenicity, ionizing radiation, and DNA damage for more than 25 years. He graduated cum laude in Zoology and Anthropology from Duke’s Trinity College, and obtained his Ph.D. at Duke in David and Jane Richardson’s laboratory. He joined Scripps as a Damon Runyon Fellow in Arthur Olson’s laboratory to work on computational tools for macromolecular structures. He then joined the Scripps faculty and rose to Full Professor. At Scripps, he pioneered structures for reactive oxygen signals and regulation by superoxide dismutases, catalase, and nitric oxide synthases. He defined the first full-length structures for the membrane and fiber-forming pilin proteins and the pilus assembly for adherence and mobility. He examined mobility in antibody interactions and developed computational algorithms for measuring flexibility, intermolecular interactions and protein surface topography.
At LBL he developed and directs SIBYLS, the world’s only dual-endstation synchrotron beamline for small angle x-ray scattering (SAXS) and macromolecular x-ray crystallography (MX), to determine accurate macromolecular structures, conformations and assemblies in solution and at high resolution. He solved and deposited more than 300 structures in the Protein Data Bank and authored more than 100 scientific publications, cited over 95 times. He defined a novel SAXS invariant, and introduced equations for objective X-ray analyses of macromolecular flexibility, mass, and similarity. At MD Anderson he focuses on DNA break and lesion repair complexes that interface repair with replication, transcription, apoptosis, and immune responses. He is the Robert A. Welch Distinguished Chair in Chemistry, director of structural biology and director of the National Cancer Institute’s Structural Biology of DNA Repair Program. Motivated by observations that infectious disease and radiotherapy abscopal effects can promote cancer cures, he is integrating structural and imaging technologies to dissect multifunctionality and enable mechanistic control of stress responses for biology and medicine.


 
PRESIDENTIAL SYMPOSIUM: Neurobiology and Radiation Sciences for the Future
       
Frank Pajonk, MD, PhD
UCLA- Radiation Oncology
Kerry O’Banion, MD, PhD
University of Rochester
Medical Center

Marcelo Wood, PhD
University of California- Irvine

Munjal Acharya, PhD, MS
University of California- Irvine
 
PAINTER DEBATE: This House Believes that the LQ Model is Not Relevant to the High Doses Per Fraction Used in SBRT
    
FOR: Mike Joiner, PhD
Wayne State University
AGAINST: Martin Brown, PhD, MSc
Emeritus- Stanford Medicine
 
OSBORNE AWARD LECTURE
 

David Kirsch, MD PhD 
David Kirsch, MD, PhD, is the Barbara Levine University Professor at Duke in the Departments of Radiation Oncology and Pharmacology & Cancer Biology. After graduating from Duke with a BS in Biology, he completed the MD/PhD program at Johns Hopkins School of Medicine, where he performed his thesis research with Dr. Michael Kastan. After an internship in Internal Medicine, Dr. Kirsch trained in radiation oncology at Massachusetts General Hospital. He worked as a post-doc in the laboratory of Dr. Tyler Jacks at M.I.T., where he developed a genetically engineered mouse model of soft tissue sarcoma. He utilized the Jacks’ lab mouse model of non-small cell lung cancer to study radiation response in vivo. In 2007 Dr. Kirsch moved to Duke, where he uses radiation therapy to care for patients with sarcomas at the Duke Cancer Center. Dr. Kirsch is the leader of the Radiation Oncology & Imaging Program in the Duke Cancer Institute and serves as Vice Chair for Basic and Translational Research in the Department of Radiation Oncology. Dr. Kirsch’s laboratory utilizes sophisticated genetically engineered mouse models to study mechanisms of tumor and normal tissue response to radiation.

 
SYMPOSIUM 23: Breast Cancer and Immune Modulation
       
Jim Welsh, MD
MD Anderson Cancer Center 
Steven Chmura, MD, PhD
University of Chicago Medicine
Janet Horton, MD
Duke Cancer Center
Weiguo Zhang, MD, MSc, PhD
Lawrence Berkeley National Laboratory
 
SYMPOSIUM 24: CRH/RRS JOINT SYMPOSIUM: Health Risks, Radiation Biomarkers and Carcinogenesis
       
Daniel Stram, PhD
University of Southern California
Eric Grant, PhD
Radiation Effects Research
Foundation
Christian Kaiser, PhD
Institute of Radiation Protection-
German Research Center for
Environmental Health
Christophe Badie, PhD, MSc
Public Health England’s Centre for
Radiation, Chemical and Environmental
Hazards
 
SYMPOSIUM 25: The Role of Non-Coding RNAs In Radiation Response
           
Norman Coleman, MD
National Cancer Institute Center for Cancer Research
Eric Chuang, Sc.D
National Taiwan University- Yonglin Biomedical Engineering Center
Naduparambil Jacob, PhD
Ohio State University Comprehensive Cancer Center
Molykutty J Aryankalayil, PhD
National Cancer Institute Center for Cancer Research
Sanchita P.Ghosh, PhD
Uniformed Services University of the Health Sciences
Nicole L. Simone, MD
Jefferson Health
 
SYMPOSIUM 26: The Importance of Dosimetry Standardization in Radiobiology
      
Brian Marples, PhD
University of Miami Health Systems
Anna Subiel, PhD
National Physical Laboratory
Ke Sheng, PhD, DABR
UCLA- Department of
Radiation Oncology

 
 
 
 



  RADIATION RESEARCH SOCIETY
380 Ice Center Lane, Suite C | Bozeman, MT 59718 | 1.877.216.1919
Member & Exhibitor Services: Audrey Rinehart |
1.877.216.1919  |  audrey@radres.org